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Patient 
Current 
age 
(y/m)    
Screening/ 
confirmation 
sampling day 
Methionine at 
screening/ 
confirmation 
(µM)* 
MAT1A 
mutations 
1 6y 6/12 85/80 R264H 
2 5y 4/19 77/121 R264H 
3 5y 4/19 52/168 R264H 
4 5y 5/18 123/176 R264H 
5 4y 4/16 103/85 R264H 
6 4y 3/29 58/247 R264H 
7 3y 4/30 80/195 R264H 
8 2y 6/10 309/194 R264H 
9 2y 4/24 85/245 R264H 
10 2y 6/70 77/157 R264H 
11 2y 6/23 73/145 R264H 
12 2y 5/24 124/155 R264H 
13 2y 5/30 91/79 R264H 
14 2y 5/30 117/182 R264H 
15 2y 7/28 67/84 
L137V/ 
S247N 
16 23m 4/20 79/111 R264H 
17 21m 3/19 71/465 
L355R/ 
L355R 
18 19m 6/24 80/147 R264H 
19 14m 5/17 60/136 R264H 
20 13m 4/13 100/105 R264H 
21 7m 6/30 63/117 R264H 
22 7m 5/19 72/85 R264H 
23 3m 3/16 71/110 R264H 
INTRODUCTION 
Methionine adenosyltransferase deficiency (MAT I/III deficiency, OMIM 250850) is an inborn error of 
metabolism resulting in isolated hypermethioninemia and usually inherited as an autosomal recessive 
trait. A dominant form has been exceptionally reported, associated with a single mutation (R264H). 
METHODS 
MAT I/III deficiency is detected by newborn screening (NBS) since 2004, as a differential diagnosis of 
classical homocystinuria. Both screenings are based in the methionine measurement by tandem mass 
spectrometry, and approximately 600,000 newborns were already screened in our laboratory.  
Suspected cases of MAT I/III deficiency are confirmed through MAT1A gene analysis.  
RESULTS 
Twenty-three MAT I/III deficient patients were 
identified through newborn screening (Table 1). 
Twelve of them (blue shadowed in Table 1) were 
identified in a small area of Douro high lands, in the 
region of Mirandela, and all revealed to be 
heterozygous for R264H mutation. Family studies 
allowed the identification of fifteen additional 
heterozygotes and the sequencing of MAT1A exon 
7 in all these 12 patients and their parents, 
confirmed the association of mutation R264H and 
the 870G (rs10887711) and 882C (rs10788546) 
MAT1A allelic variants (Table 2), as previously 
reported (Chamberlin et al 1997).  
Clinical follow-up of these 12 patients revealed 
normal growth, development and neurological 
examination in all cases, but positive histories for 
severe vascular disease were referred in three  
families and patient 7 revealed to have myelination 
alterations. 
Table 1: MAT I/III deficient patients identified through NBS 
Table 2: MAT1A exon 7 polymorphic variants associated with 
R264H allele 
MAT1A allele rs10887711 rs10788546 
Normal G or A C or T 
R264H G C 
*Normal Met < 50µM 
DISCUSSION 
The first cause of persistent isolated hypermethioninemia in Portuguese newborns is MAT I/III 
deficiency (estimated frequency: 1:26,000), and in 21 out of 23 cases identified through NBS, this 
condition is due to R264H heterozygosity. 
Clinical outcome associated with this mutation is usually good (Pérez-Mato et al 2001) but family 
studies performed in 12 patients, identified in a small geographic area in the region of Mirandela, 
revealed clinical manifestations in several individuals, which may be related with this condition and 
reinforces the importance of carriers identification and counseling. 
As far as we could investigate from family histories, these 12 patients are not related, and the fact that 
R264H mutation was found in all individuals associated with the same MAT1A exon 7 polymorphic 
variants may indicate a hot spot for R264H allele in this region.  
